Rhythm Pharmaceuticals


Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity.


Org chart

David Meeker
Chairman, President & CEO
Collapse
Pam Cramer
Chief Human Resource Officer
Yann Mazabraud
EVP, Head of International
Jennifer Chien
EVP, Head of North America
Jim Flaherty
SVP & General Counsel
Joe Shulman
SVP, Technical Solutions
Dana Washburn
SVP, Clinical Development
Dr. Bibiana da Rocha
General Manager Iberia

Board & advisors

Ed Mathers
Lead Independent Director
Jennifer Good
Board Member